Vanguard Personalized Indexing Management, LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Vanguard Personalized Indexing Management, LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$928,000
+77.4%
7,841
+77.1%
0.14%
+22.8%
Q4 2020$523,000
+55.2%
4,427
+46.2%
0.11%
+20.0%
Q3 2020$337,000
+30.6%
3,029
+20.2%
0.10%
-18.8%
Q2 2020$258,000
-66.9%
2,521
-65.1%
0.12%
-74.3%
Q1 2020$780,0007,2310.46%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders